Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China flag China · Delayed Price · Currency is CNY
22.83
-0.12 (-0.52%)
Jan 23, 2026, 3:00 PM CST

SHA:605177 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Operating Revenue
821.81,1881,3511,174702.06878.65
Upgrade
Other Revenue
9.769.765.865.2810.163.02
Upgrade
831.561,1981,3561,180712.22881.67
Upgrade
Revenue Growth (YoY)
-36.76%-11.66%15.00%65.62%-19.22%-10.77%
Upgrade
Cost of Revenue
742.341,0041,008913.49521.62588.04
Upgrade
Gross Profit
89.22194.21348.75266.06190.6293.63
Upgrade
Selling, General & Admin
174.33179.97146.85122.72116.33126.75
Upgrade
Research & Development
116.11117.0281.7444.9537.2938.41
Upgrade
Other Operating Expenses
11.646.275.68.575.211.2
Upgrade
Operating Expenses
297.01304.11236.91177.54157.81177.22
Upgrade
Operating Income
-207.79-109.91111.8488.5232.79116.41
Upgrade
Interest Expense
-9.77-2.04-3.6-0.84-0.22-0.66
Upgrade
Interest & Investment Income
7.829.6218.2621.2728.974.43
Upgrade
Currency Exchange Gain (Loss)
3.133.130.82.22-0.68-2.1
Upgrade
Other Non Operating Income (Expenses)
2.33-1.09-0.82-0.51-0.56-0.39
Upgrade
EBT Excluding Unusual Items
-204.27-100.29126.48110.6660.3117.68
Upgrade
Gain (Loss) on Sale of Assets
-18.27-15.73-5.69-5.54-4.05-2.45
Upgrade
Asset Writedown
-42.57-11.37----
Upgrade
Other Unusual Items
10.089.2213.99.9720.8114.96
Upgrade
Pretax Income
-255.03-118.17134.69115.0977.06130.19
Upgrade
Income Tax Expense
-36.73-17.4713.4410.678.5715.71
Upgrade
Earnings From Continuing Operations
-218.3-100.7121.25104.4368.49114.48
Upgrade
Minority Interest in Earnings
0.060.04----
Upgrade
Net Income
-218.24-100.66121.25104.4368.49114.48
Upgrade
Net Income to Common
-218.24-100.66121.25104.4368.49114.48
Upgrade
Net Income Growth
--16.11%52.46%-40.17%-31.99%
Upgrade
Shares Outstanding (Basic)
11311211311411487
Upgrade
Shares Outstanding (Diluted)
11311212511411487
Upgrade
Shares Change (YoY)
-21.22%-10.52%10.13%-0.57%30.62%2.79%
Upgrade
EPS (Basic)
-1.93-0.901.070.920.601.31
Upgrade
EPS (Diluted)
-1.93-0.900.970.920.601.31
Upgrade
EPS Growth
--5.44%53.33%-54.20%-33.84%
Upgrade
Free Cash Flow
-410.49-368.16-311.53-158.17-145.5785.82
Upgrade
Free Cash Flow Per Share
-3.62-3.29-2.49-1.39-1.270.98
Upgrade
Dividend Per Share
--0.3270.2900.2000.350
Upgrade
Dividend Growth
--12.63%45.00%-42.86%94.44%
Upgrade
Gross Margin
10.73%16.21%25.71%22.56%26.76%33.30%
Upgrade
Operating Margin
-24.99%-9.17%8.24%7.51%4.60%13.20%
Upgrade
Profit Margin
-26.25%-8.40%8.94%8.85%9.62%12.98%
Upgrade
Free Cash Flow Margin
-49.36%-30.73%-22.97%-13.41%-20.44%9.73%
Upgrade
EBITDA
-58.7921.69220.24180.68101.97179.39
Upgrade
EBITDA Margin
-7.07%1.81%16.24%15.32%14.32%20.35%
Upgrade
D&A For EBITDA
149131.6108.492.1569.1862.98
Upgrade
EBIT
-207.79-109.91111.8488.5232.79116.41
Upgrade
EBIT Margin
-24.99%-9.17%8.24%7.51%4.60%13.20%
Upgrade
Effective Tax Rate
--9.98%9.27%11.12%12.06%
Upgrade
Revenue as Reported
831.561,1981,3561,180712.22881.67
Upgrade
Advertising Expenses
-3.232.50.081.742.13
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.